Abstract

Taurine for the Treatment of Canine Dilated Cardiomyopathy

Author(s): Vail Jane

Issue: Nov/Dec 2006 - Veterinary Compounding

Page(s): 421-424

Download in electronic PDF format for $75
  • Taurine for the Treatment of Canine Dilated Cardiomyopathy Page 1
  • Taurine for the Treatment of Canine Dilated Cardiomyopathy Page 2
  • Taurine for the Treatment of Canine Dilated Cardiomyopathy Page 3
  • Taurine for the Treatment of Canine Dilated Cardiomyopathy Page 4

Abstract

In dogs, dilated cardiomyopathy is a common cardiac disease that is associated with treatment failure, a progressively compromised quality of life, and eventual death from heart failure. Cardiomyopathy in companion animals is treated with a variety of drugs manufactured for the management of cardiac dysfunction in humans, but often those agents do not produce a significantly beneficial response in veterinary patients. In this article, Laura Ivan, DVM, presents her personal experience with the use of a compounded form of the amino acid taurine in the treatment of her Doberman pinscher, whose dilated cardiomyopathy was characteristically sudden in onset. Robert Borger, RPh, a specialist in veterinary compounding, comments on the preparation of taurine for use in dogs with dilated cardiomyopathy.

Related Keywords

  • Jane Vail
  • dogs
  • dilated cardiomyopathy
  • heart disorders
  • cardiac disorders
  • congestive heart failure
  • taurine
  • amino acids
  • veterinary

Related Categories

  • NUTRITION AND NUTRICEUTICALS
  • VETERINARY
  • CARDIOLOGY
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2006
Pg. 421-424
Taurine for the Treatment of Canine Dilated Cardiomyopathy
Author(s): Vail Jane
Mar/Apr 2003
Pg. 106-113
Veterinary Transdermal Medications: A to Z
Author(s): Davidson Gigi S
May/Jun 2003
Pg. 188-191
Treating Canine Hepatic Disease
Author(s): Davidson Gigi S
Sep/Oct 2009
Pg. 367-371
Congestive Heart Failure and Other Medical Facts About Ferrets; Scout's Story: A Case Report on Treating Congestive Heart Failure in a Ferret
Author(s): Williams LaVonn A, Riley Kari
Jul/Aug 2003
Pg. 266-270
Sensitization Therapy for Warts
Author(s): Kuntz Rachael
Mar/Apr 2010
Pg. 108-111
Coenzyme Q10 Supplementation in the Treatment of Heart Disease
Author(s): Bramwell Bethany L
Jan/Feb 2012
Pg. 34-41
Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension
Author(s): Helms Scott R, Fox Samantha, Mixon William, Vail Jane
Jan/Feb 2004
Pg. 46-48
Basics of Compounding for Disorders of the External Ear
Author(s): Allen Loyd V Jr
Sep/Oct 2009
Pg. 386-389
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Author(s): Williams LaVonn A, Fokken Dawn
Mar/Apr 1999
Pg. 88-98
Natural Testosterone: Hormone of the Heart
Author(s): Wright Jonathan V, Lenard Lane
Jul/Aug 2003
Pg. 288-291
Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew
Sep/Oct 2008
Pg. 384-390
Canine Public Servants: Caring for Drug Detection Dogs
Author(s): Davidson Gigi S
Jul/Aug 2016
Pg. 277-280
Case Report: Pediatric Scar Management After Open-heart Surgery
Author(s): Phan Ha, Harger Beau, Estrada Nick
Jul/Aug 1999
Pg. 309-310
Acidifying Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Jul/Aug 2005
Pg. 275-278
Compounding for Endocrine Disorders in Adult Patients
Author(s): Grajeda Betty Jo, Vail Jane
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Mar/Apr 1997
Pg. 87-89
Attention Deficit Hyperactivity Disorder
Author(s): Allen Loyd V Jr
Jan/Feb 2001
Pg. 21-22
Methylphenidate in the Treatment of Attention Deficit Disorders
Author(s): Tenreiro Kim
May/Jun 2006
Pg. 227
Quinapril 1-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Jul/Aug 2011
Pg. 302-307
Treating Inner Ear Disorders with Intratympanic Drug Administration
Author(s): McElhiney Linda F